Biomaterial Database

[Thrombotic microangiopathy]. 2003

C Chiurchiu, and G Remuzzi

Clinical Research Center for Rare Diseases, Aldo e Cele Daccò, Villa Camozzi, Ranica, Bergamo, Italy. manuelap@marionegri.it

UI	MeSH Term	Description	Entries
D011697	Purpura, Thrombotic Thrombocytopenic	An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.	Moschkowitz Disease,Purpura, Thrombotic Thrombopenic,Thrombotic Thrombocytopenic Purpura, Congenital,Thrombotic Thrombocytopenic Purpura, Familial,Congenital Thrombotic Thrombocytopenic Purpura,Familial Thrombotic Thrombocytopenia Purpura,Familial Thrombotic Thrombocytopenic Purpura,Microangiopathic Hemolytic Anemia, Congenital,Moschcowitz Disease,Schulman-Upshaw Syndrome,Thrombotic Microangiopathy, Familial,Thrombotic Thrombocytopenic Purpura,Upshaw Factor, Deficiency of,Upshaw-Schulman Syndrome,Familial Thrombotic Microangiopathy,Microangiopathy, Familial Thrombotic,Schulman Upshaw Syndrome,Thrombocytopenic Purpura, Thrombotic,Thrombopenic Purpura, Thrombotic,Thrombotic Thrombopenic Purpura,Upshaw Schulman Syndrome
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D006463	Hemolytic-Uremic Syndrome	A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.	Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Chiurchiu, and G Remuzzi

Thrombotic microangiopathy.

January 1990, Advances in experimental medicine and biology,

C Chiurchiu, and G Remuzzi

[Thrombotic microangiopathy].

August 2006, [Rinsho ketsueki] The Japanese journal of clinical hematology,

C Chiurchiu, and G Remuzzi

[Thrombotic microangiopathy].

June 2011, Polish journal of pathology : official journal of the Polish Society of Pathologists,

C Chiurchiu, and G Remuzzi

Thrombotic microangiopathy.

June 2000, European journal of internal medicine,

C Chiurchiu, and G Remuzzi

Thrombotic microangiopathy.

July 1954, British medical journal,

C Chiurchiu, and G Remuzzi

Thrombotic microangiopathy.

October 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis,

C Chiurchiu, and G Remuzzi

[Thrombotic microangiopathy].

September 2013, Der Internist,

C Chiurchiu, and G Remuzzi

[Thrombotic microangiopathy].

January 2021, Der nephrologe,

C Chiurchiu, and G Remuzzi

[Thrombotic microangiopathy].

November 2006, Rinsho shinkeigaku = Clinical neurology,

C Chiurchiu, and G Remuzzi

[Thrombotic microangiopathy].

February 2023, Medizinische Klinik, Intensivmedizin und Notfallmedizin,